Profil
Gilad Rosenberg worked as a Medical Director at Clal Biotechnology Industries Ltd.
and Organon Pharma (UK) Ltd.
He then worked as Vice President-Clinical Development at Univo Pharmaceuticals Ltd.
from 2000 to 2016.
Rosenberg received an undergraduate degree from Technion-Israel Institute of Technology in 1992 and a graduate degree from the University of Oxford in 2005.
Anciens postes connus de Gilad Rosenberg
| Sociétés | Poste | Fin |
|---|---|---|
| UNIVO PHARMACEUTICALS LTD | Corporate Officer/Principal | 07/05/2016 |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Directeur Technique/Scientifique/R&D | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Gilad Rosenberg
| Technion-Israel Institute of Technology | Undergraduate Degree |
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| UNIVO PHARMACEUTICALS LTD | Health Technology |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| Entreprise privées | 1 |
|---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |